Imaging for assessment of sudden death risk: current role and future prospects.
暂无分享,去创建一个
Michael Jerosch-Herold | Saman Nazarian | S. Chugh | M. Jerosch-Herold | S. Nazarian | Takeki Suzuki | Takeki Suzuki | Sumeet S Chugh
[1] Jeroen J. Bax,et al. The relationship between time from myocardial infarction, left ventricular dyssynchrony, and the risk for ventricular arrhythmia: speckle-tracking echocardiographic analysis. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[2] C. Kramer,et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.
[3] S. Chugh,et al. Prediction of sudden cardiac death: next steps in pursuit of effective methodology , 2011, Journal of Interventional Cardiac Electrophysiology.
[4] James O. Mudd,et al. T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.
[5] D. Mozaffarian,et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[6] J. Svendsen,et al. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. , 2013, JACC. Cardiovascular imaging.
[7] É. Marijon,et al. Frequency and Determinants of Implantable Cardioverter Defibrillator Deployment Among Primary Prevention Candidates With Subsequent Sudden Cardiac Arrest in the Community , 2013, Circulation.
[8] S. Dorbala,et al. Selected review article based on ASNC meeting presentationIntegrated cardiac PET-CT for the diagnosis and management of CAD , 2006 .
[9] Laurie Zoloth,et al. Risk Stratification for Sudden Cardiac Death: A Plan for the Future , 2014, Circulation.
[10] G. Korosoglou,et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.
[11] B. Lindsay,et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri , 2013, Journal of the American College of Cardiology.
[12] Raymond J Kim,et al. Frontiers in cardiovascular magnetic resonance. , 2005, Circulation.
[13] A. Taylor,et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. , 2012, European heart journal cardiovascular Imaging.
[14] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.
[15] James E. Muller,et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. , 2008, JACC. Cardiovascular imaging.
[16] K. Reinier,et al. Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. , 2011, Heart rhythm.
[17] Richard D. White,et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.
[18] A. Castellanos,et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.
[19] C. Albert,et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: too little and too late? , 2013, Circulation.
[20] M. Hori,et al. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging , 2007, Heart.
[21] M. Phelps,et al. PET: the merging of biology and imaging into molecular imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Ruben Coronel,et al. Activation Delay After Premature Stimulation in Chronically Diseased Human Myocardium Relates to the Architecture of Interstitial Fibrosis , 2001, Circulation.
[23] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[24] M. Cerqueira,et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.
[25] H. Wellens,et al. Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. , 2003, European heart journal.
[26] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[27] H. Dargie,et al. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1987, The New England journal of medicine.
[28] M. Travin,et al. Radionuclide imaging of cardiac autonomic innervation , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[29] A. Tajik,et al. Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.
[30] K. Reinier,et al. Epidemiology of sudden cardiac death: clinical and research implications. , 2008, Progress in cardiovascular diseases.
[31] R C Barr,et al. Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. , 2000, Circulation research.
[32] P R Ershler,et al. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. , 1993, The Journal of clinical investigation.
[33] P. Kellman,et al. Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.
[34] David A Bluemke,et al. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA , 2012, Journal of Cardiovascular Magnetic Resonance.
[35] Gregg W Stone,et al. Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction , 2011, Circulation. Cardiovascular interventions.
[36] R. Mitchell,et al. Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance: Implications for Early Cardiac Remodeling , 2013, Circulation.
[37] Jianhua Yao,et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. , 2012, Radiology.
[38] H. Brunner,et al. Congenital anomalies of the coronary arteries: imaging with contrast-enhanced, multidetector computed tomography , 2005, European Radiology.
[39] Andrew S Flett,et al. Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.
[40] K. Dimopoulos,et al. Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot , 2012, Circulation.
[41] Udo Sechtem,et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[42] Michael Jerosch-Herold,et al. Role of Transcytolemmal Water-Exchange in Magnetic Resonance Measurements of Diffuse Myocardial Fibrosis in Hypertensive Heart Disease , 2013, Circulation. Cardiovascular imaging.
[43] Jagat Narula,et al. Imaging vulnerable plaque by ultrasound. , 2006, Journal of the American College of Cardiology.
[44] R. Mohiaddin,et al. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies , 2012, Journal of Cardiovascular Magnetic Resonance.
[45] Katja Zeppenfeld,et al. Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.
[46] M. Majmudar,et al. Cardiovascular Molecular Imaging: The Road Ahead , 2012, The Journal of Nuclear Medicine.
[47] C. White,et al. Anomalous coronary arteries in adults: depiction at multi-detector row CT angiography. , 2005, Radiology.
[48] Katherine C. Wu,et al. Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.
[49] Stephan G Nekolla,et al. Cardiovascular molecular imaging: an overview. , 2009, Cardiovascular research.
[50] M. Robson,et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.
[51] Takashi Morita,et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.
[52] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[53] C. O'connor,et al. Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%. , 2010, Journal of the American College of Cardiology.
[54] Karen L. Gunson,et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. , 2006, Journal of the American College of Cardiology.
[55] Antonio Berruezo,et al. 3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[56] E. Saloux,et al. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[57] A. Curtis,et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. , 2014, Journal of the American College of Cardiology.
[58] T. Nakata,et al. Impaired Cardiac Sympathetic Innervation and Myocardial Perfusion Are Related to Lethal Arrhythmia: Quantification of Cardiac Tracers in Patients with ICDs , 2010, The Journal of Nuclear Medicine.
[59] S. Heymans,et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. , 2015, Heart rhythm.
[60] Hirofumi Anno,et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. , 2009, Journal of the American College of Cardiology.
[61] K. Croce,et al. Optical Coherence Tomography , 2012, Circulation.
[62] Jacques Ohayon,et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. , 2012, JACC. Cardiovascular imaging.
[63] T. Nakata,et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[64] Mark E. Anderson,et al. Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.
[65] R. Ruiz-Granell,et al. Value of Early Cardiovascular Magnetic Resonance for the Prediction of Adverse Arrhythmic Cardiac Events After a First Noncomplicated ST-Segment–Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular imaging.
[66] Yasunori Ueda,et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy. , 2006, Journal of the American College of Cardiology.
[67] Tevfik F Ismail,et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.
[68] Ralph Weissleder,et al. Molecular imaging of cardiovascular disease. , 2007, Circulation.
[69] Sergio Waxman,et al. Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. , 2006, Journal of interventional cardiology.
[70] Warren J Manning,et al. Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.
[71] G. Breithardt,et al. Cardiac Autonomic Dysfunction in Brugada Syndrome , 2002, Circulation.
[72] Ralph Weissleder,et al. Molecular and cellular imaging of atherosclerosis: emerging applications. , 2006, Journal of the American College of Cardiology.
[73] J. Piccini,et al. Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death , 2008, Circulation. Cardiovascular imaging.
[74] D. Bluemke,et al. 3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis. , 2013, Journal of cardiovascular computed tomography.
[75] R. Blankstein,et al. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. , 2015, European heart journal cardiovascular Imaging.
[76] Akiko Maehara,et al. A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.
[77] P. Stone,et al. Circadian variation and triggers of onset of acute cardiovascular disease. , 1989, Circulation.
[78] P. Kistler,et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. , 2011, Journal of the American College of Cardiology.
[79] A. Moss,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.
[80] Brett E. Bouma,et al. In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography , 2005, Circulation.
[81] Chun Yuan,et al. In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.
[82] P. Mangin,et al. Postmortem imaging of sudden cardiac death , 2013, International Journal of Legal Medicine.
[83] S. Chugh. Early identification of risk factors for sudden cardiac death , 2010, Nature Reviews Cardiology.
[84] Jeroen J. Bax,et al. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. , 2010, The American journal of cardiology.
[85] P. Willeit,et al. Left Ventricular Mass and the Risk of Sudden Cardiac Death: A Population‐Based Study , 2014, Journal of the American Heart Association.
[86] Sabino Iliceto,et al. Three-Dimensional Electroanatomic Voltage Mapping Increases Accuracy of Diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2005, Circulation.
[87] Robert G. Weiss,et al. Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.
[88] J. Gillard,et al. Noninvasive imaging of carotid plaque inflammation , 2004, Neurology.
[89] D. Corrado,et al. Prognostic Value of Endocardial Voltage Mapping in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2013, Circulation. Arrhythmia and electrophysiology.
[90] M. Fishbein,et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. , 1998, Journal of the American College of Cardiology.
[91] E. Cook,et al. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.
[92] K. Lee,et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.
[93] M. D. Di Carli,et al. Integrated cardiac PET-CT for the diagnosis and management of CAD. , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[94] C. Tracy,et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.
[95] R. Virmani,et al. Pathology of the Vulnerable Plaque , 2006 .
[96] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[97] J. Silva-Cardoso,et al. Cardiac 123I-MIBG scintigraphy and arrhythmic risk in left ventricular noncompaction. , 2012, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[98] Sanjiv J Shah,et al. Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.
[99] Ciprian Catana,et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[100] Katherine C. Wu,et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[101] T. Edvardsen,et al. Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations. , 2015, JACC. Cardiovascular imaging.
[102] A. Uy‐Evanado,et al. Electrocardiographic versus echocardiographic left ventricular hypertrophy and sudden cardiac arrest in the community. , 2014, Heart rhythm.
[103] H. Wellens,et al. Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. , 1997, Journal of the American College of Cardiology.
[104] D. Pennell,et al. Prognostic role of CMR in patients presenting with ventricular arrhythmias. , 2013, JACC. Cardiovascular imaging.
[105] Andrea Mazzanti,et al. [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.
[106] S. Chugh,et al. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro , 2007, The International Journal of Cardiovascular Imaging.
[107] M. Janse,et al. Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. , 1996, Journal of the American College of Cardiology.
[108] D. Levy,et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.
[109] M. Travin,et al. Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death , 2012, Journal of Nuclear Cardiology.
[110] Titus Kuehne,et al. Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping , 2011, Circulation. Cardiovascular imaging.